Contents:

H.-H. Neumayer: 
Preface

N. Maham, E. Cole: 
The Use of C2 Monitoring in Renal Transplantation to Optimize Cyclosporine Exposure

K. Budde, K.-P. Braun, P. Glander, P. Hambach, L. Fritsche, J. Waiser, H.-H. Neumayer:
Pharmacodynamic Monitoring of Mycophenolate Mofetil

I. A. Hauser: 
The Importance of Multidrug-Resistence P-Glycoprotein in Renal Transplantation

S. Padmanabhan, N. Padmanabhan, A. G. Jardine: 
Genetic Polymorphisms and Renal Transplantation

M. Fischereder, B. Krüger, B. K. Krämer: 
Chemokine and Renal Transplantation

A. Schwarting, E. Wandel, P. R. Galle: 
Anti-Endothelcell-Antibody and Transplantation

D. Dragun, K. Sacherer, M. Giessing, K. Budde, H.-H. Neumayer: 
Importance of Ischemia-Reperfusion Injury for Renal Transplantation

B. Fellström: 
Chronic Renal Allograft Dysfunction

H. Holdaas, A. Jardine: 
Hyperlipidämie in Renal Transplantation

K. Midtvedt, A. Hartmann: 
Hypertension after Renal Transplantation

V. Ebeling, I. Türk, S. Deger, M. Giessing, S. A. Loening: 
Laparoscopic Donornephrectomy – Pro and Contra

T. Böhler, J. Waiser, M. Schütz, K. Budde: 
FTY720: Development of a Novel and Unique, Immunmodulating Drug that has the Potential to Revolutionize Transplantation Medicine